KEYNOTE-365 cohort B updated results: Pembrolizumab (pembro) plus docetaxel and prednisone in abiraterone (abi) or enzalutamide (enza) pre-treated patients with metastatic castration-resistant prostate cancer (mCRPC)

Autor:	G. Gravis, M. Kolinsky, L. Mourey, J.M. Piulats, S. Sridhar, E. Romano, W. Berry, H. Gurney, M. Retz, L. Appleman, M. Boegemann, J. De Bono, A. Joshua, U. Emmenegger, H. Conter, B. Laguerre, H. Wu, C. Schloss, C. Poehlein, E.Y. Yu
Jazyk:	angličtina
Rok vydání:	2020
Předmět:	Diseases of the genitourinary system. Urology RC870-923 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Zdroj:	European Urology Open Science, Vol 19, Iss , Pp e871-e872 (2020)
Druh dokumentu:	article
ISSN:	2666-1683
DOI:	10.1016/S2666-1683(20)33163-3
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/714426087a914766a3f6599eaa157ff7 Zobrazit plný text záznamu View record in DOAJ